Study Examines Impact of Cost Sharing on Specialty Drug Use
12/
21
Study Examines Impact of Cost Sharing on Specialty Drug Use
A study in the American Journal of Managed Care found that reductions in the use of specialty drugs in rheumatoid arthritis, cancer and multiple sclerosis are generally associated with higher cost sharing, though the effects vary by disease type.